Your browser doesn't support javascript.
loading
Preclinical evaluation of the mTOR-PI3K inhibitor BEZ235 in nasopharyngeal cancer models.
Ma, Brigette B Y; Lui, Vivian W Y; Hui, Connie W C; Lau, Cecilia P Y; Wong, Chi H; Hui, Edwin P; Ng, Margaret H L; Cheng, Suk H; Tsao, Sai W; Tsang, Chi-Man; Cheung, Crystal S F; Ho, Kakiu; Chan, Anthony T C.
Afiliação
  • Ma BB; State Key Laboratory in Oncology in South China, Sir Y.K. Pao Centre for Cancer, Department of Clinical Oncology, Cancer Drug Testing Unit, Hong Kong Cancer Institute and Li Ka Shing Institute of Health Sciences, Chinese University of Hong Kong, Hong Kong Special Administrative Region. Electronic ad
  • Lui VW; Department of Otolaryngology, University of Pittsburgh, USA.
  • Hui CW; State Key Laboratory in Oncology in South China, Sir Y.K. Pao Centre for Cancer, Department of Clinical Oncology, Cancer Drug Testing Unit, Hong Kong Cancer Institute and Li Ka Shing Institute of Health Sciences, Chinese University of Hong Kong, Hong Kong Special Administrative Region.
  • Lau CP; State Key Laboratory in Oncology in South China, Sir Y.K. Pao Centre for Cancer, Department of Clinical Oncology, Cancer Drug Testing Unit, Hong Kong Cancer Institute and Li Ka Shing Institute of Health Sciences, Chinese University of Hong Kong, Hong Kong Special Administrative Region.
  • Wong CH; State Key Laboratory in Oncology in South China, Sir Y.K. Pao Centre for Cancer, Department of Clinical Oncology, Cancer Drug Testing Unit, Hong Kong Cancer Institute and Li Ka Shing Institute of Health Sciences, Chinese University of Hong Kong, Hong Kong Special Administrative Region.
  • Hui EP; State Key Laboratory in Oncology in South China, Sir Y.K. Pao Centre for Cancer, Department of Clinical Oncology, Cancer Drug Testing Unit, Hong Kong Cancer Institute and Li Ka Shing Institute of Health Sciences, Chinese University of Hong Kong, Hong Kong Special Administrative Region.
  • Ng MH; Department of Anatomical and Cellular Pathology, Chinese University of Hong Kong, Hong Kong Special Administrative Region.
  • Cheng SH; Department of Anatomical and Cellular Pathology, Chinese University of Hong Kong, Hong Kong Special Administrative Region.
  • Tsao SW; Department of Anatomy, University of Hong Kong, Hong Kong Special Administrative Region.
  • Tsang CM; Department of Anatomy, University of Hong Kong, Hong Kong Special Administrative Region.
  • Cheung CS; State Key Laboratory in Oncology in South China, Sir Y.K. Pao Centre for Cancer, Department of Clinical Oncology, Cancer Drug Testing Unit, Hong Kong Cancer Institute and Li Ka Shing Institute of Health Sciences, Chinese University of Hong Kong, Hong Kong Special Administrative Region.
  • Ho K; State Key Laboratory in Oncology in South China, Sir Y.K. Pao Centre for Cancer, Department of Clinical Oncology, Cancer Drug Testing Unit, Hong Kong Cancer Institute and Li Ka Shing Institute of Health Sciences, Chinese University of Hong Kong, Hong Kong Special Administrative Region.
  • Chan AT; State Key Laboratory in Oncology in South China, Sir Y.K. Pao Centre for Cancer, Department of Clinical Oncology, Cancer Drug Testing Unit, Hong Kong Cancer Institute and Li Ka Shing Institute of Health Sciences, Chinese University of Hong Kong, Hong Kong Special Administrative Region.
Cancer Lett ; 343(1): 24-32, 2014 Feb 01.
Article em En | MEDLINE | ID: mdl-24041865

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Quinolinas / Regulação Neoplásica da Expressão Gênica / Neoplasias Nasofaríngeas / Fosfatidilinositol 3-Quinases / Serina-Treonina Quinases TOR / Imidazóis Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2014 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Quinolinas / Regulação Neoplásica da Expressão Gênica / Neoplasias Nasofaríngeas / Fosfatidilinositol 3-Quinases / Serina-Treonina Quinases TOR / Imidazóis Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2014 Tipo de documento: Article